Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510),a novel A1-adenosine receptor agonist
Authors:
- Eric N PrystowskyEric N Prystowsky
- Anwer DhalaADAnwer Dhala
- Richard I FogelRFRichard I Fogel
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Electrophysiologic Effects of a Novel Selective Adenosine A1 Agonist (CVT-510) on Atrioventricular Nodal Conduction in HumansJournal of Cardiovascular Pharmacology and Therapeutics, 2001
- Role of A2A‐adenosine receptor activation for ATP‐mediated coronary vasodilation in guinea‐pig isolated heartBritish Journal of Pharmacology, 2000
- A comparison of an A1 adenosine receptor agonist (CVT‐510) with diltiazem for slowing of AV nodal conduction in guinea‐pigBritish Journal of Pharmacology, 1999
- Adenosine and Adenosine Receptors in the Cardiovascular System: Biochemistry, Physiology, and PharmacologyThe American Journal of Cardiology, 1997
- Ionic basis of the electrophysiological actions of adenosine on cardiomyocytesThe FASEB Journal, 1995
- Effects of adenosine on atrial refractoriness and arrhythmiasCardiovascular Research, 1994
- Electrophysiological basis for the use of adenosine in the diagnosis and treatment of cardiac arrhythmias.Heart, 1990
- The cardiac effects of adenosineProgress in Cardiovascular Diseases, 1989
- Effect of adenosine on atrioventricular conduction. I: Site and characterization of adenosine action in the guinea pig atrioventricular node.Circulation Research, 1986
- Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmiasJACC, 1985